Transgenic mice of both sexes lacking hepatic AR showed attenuation of HCC development, suggesting that AR expression increases HCC risk possibly by increasing oxidative stress and DNA damage and reducing p53-mediated DNA repair and apoptosis [108]. Here, TP53 is linked to hepatocellular carcinoma.